MENU
+Compare
BMED
ETF ticker: NYSE ARCA
AS OF
Apr 23, 11:00 AM (EDT)
Price
$23.66
Change
+$0.46 (+1.98%)
Net Assets
2.78M

BMED stock forecast, quote, news & analysis

The investment seeks to maximize total return... Show more

Category: #Health
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX).

Industry description

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Market Cap

The average market capitalization across the iShares Health Innovation Active ETF ETF is 34.05B. The market cap for tickers in the group ranges from 84.94M to 380.22B. JNJ holds the highest valuation in this group at 380.22B. The lowest valued company is VIGL at 84.94M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 47%. For the same ETF, the average monthly price growth was 27%, and the average quarterly price growth was 122%. MTSR experienced the highest price growth at 26%, while TWST experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 5%. For the same stocks of the ETF, the average monthly volume growth was -54% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 74
Price Growth Rating: 68
SMR Rating: 75
Profit Risk Rating: 76
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
BlackRock ETF Trust100 BELLEVUE PARKWAY
Phone
N/A
Web
www.blackrock.com